Suvretta Capital Management, LLC Immatics N.V. Transaction History
Suvretta Capital Management, LLC
- $2.28 Billion
- Q1 2025
A detailed history of Suvretta Capital Management, LLC transactions in Immatics N.V. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 9,135,029 shares of IMTX stock, worth $54.3 Million. This represents 1.8% of its overall portfolio holdings.
Number of Shares
9,135,029
Previous 5,065,277
80.35%
Holding current value
$54.3 Million
Previous $36 Million
14.39%
% of portfolio
1.8%
Previous 1.5%
Shares
3 transactions
Others Institutions Holding IMTX
# of Institutions
83Shares Held
91.1MCall Options Held
201KPut Options Held
109K-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.7MShares$87.2 Million0.04% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$55.7 Million1.77% of portfolio
-
Wellington Management Group LLP Boston, MA8.58MShares$51 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$43.2 Million0.39% of portfolio
-
Vestal Point Capital, LP New York, NY7.19MShares$42.7 Million2.32% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $453M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...